SummaryRMgm-5376
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 38554111 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Nishi T, Iwanaga S, Yuda M |
Name Group/Department | Department of Medicine |
Name Institute | Mie University |
City | Tsu |
Country | Japan |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5376 |
Principal name | CALM::GFP |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not tested |
Gametocyte/Gamete | Evidence presented for expression in male gametocytes and not in females |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation For information on the gSNF2 protein: see mutant RMgm-5363 To further confirm the absence of male gametocytes in garid(−), garid was knocked out in the gametocyte reporter line 820cl1 (garid[−]820), which have GFP and RFP expression cassettes under the control of male- and female-specific promoters, respectively. FACS analysis detected no GFP-positive parasites in the garid(−)820 parasites compared with the parental 820cl1 wherein approximately 3% of the parasites showed a GFP signal. This confirmed that disruption of garid results in the complete loss of male production. Notably, the genome-wide peak pattern of the ChIP-seq of gARID was almost identical to that of gSNF2, previously reported. gSNF2 is a core subunit of SWI/SNF2 chromatin remodeling complex expressed in gametocytes, and gsnf2 knockout parasite (gsnf2[−]) showed impaired male gametocyte development. However, the knockout phenotypes are of not the same; gsnf2(−) produces immature male gametocytes, whereas garid(−) completely loses the ability to differentiate into male gametocytes. In addition, female gametocyte development was affected in garid(−) but not in gsnf2(−). Consistent with the differences in their phenotype, the results in the differential expression analyses for garid(−) vs. wild type and gsnf2(−) vs. wild type were also different. A transgenic line expressing GFP-tagged gARID (gARID::GFP) was generated with the CRISPR/Cas9 system using Pbcas9, and then, gsnf2 was disrupted in the gARID::GFPC (gARID::GFPC_gsnf2(−)). Analysis is of this mutant provided evidence that gARID is recruited by gSNF2 as a subunit of the SWI/SNF complex on the TGTCT motifs. In a previous study, it was shown that the female-specific transcriptional activator, PFG, is responsible for recognizing the TGTAYRTACA motifs. Therefore, gARID is recruited to the TGTAYRTACA motifs by PFG independent of gSNF2. In addition to the ten-base motif, the TGCACA motif was also enriched around the peak summits identified in the ChIP-seq using gARID::GFPC_gsnf2(−) suggesting that it could be another important gARID-associated sequence motif. To investigate the function of the TGCACA motif as a cis-regulatory element and the relationship between the TGTCT and TGCACA motifs in male gametocyte development, reporter assays were performed using endogenous loci. As a target for the reporter assays, the following two genes were selected: calm (PBANKA_1421000, a putative calmodulin gene) as a gene significantly down-regulated in garid(−) but only slightly in gsnf2(−) and rsph9 (PBANKA_1431500, a gene encoding a putative radial spoke head protein 9 homolog, a component of radial spokes which control axonemal dynein activity) as a gene downregulated in both garid(−) and gsnf2(−) . First, each of these genes was tagged with gfp to assess their expression using FACS (CALM::GFP and RSPH9::GFP. Then, the TGTCT and TGCACA motifs were mutated, either or both, within the peak regions located upstream of calm and rsph9 to assess the roles of these two cis-regulatory elements in the activation of male genes. |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1421000 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0714400 | ||||||||||||||||||||||||||
Gene product | calmodulin, putative | ||||||||||||||||||||||||||
Gene product: Alternative name | CALM | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | CRISPR/Cas9 construct: integration through double strand break repair | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | For tagging gARID with fluorescent proteins, knockout of garid, and knockout of gsnf2 for gARID::GFPC_gsnf2(−), the conventional homologous recombination method was used. For tagging experiments, two homologous regions of the garid locus were cloned into the mNG- or gfp-fusion vector to fuse garid in-frame with mNG or gfp. The vector was linearized using restriction enzymes before performing transfection experiments. For knockout experiments, targeting constructs, which contain a hdhfr expression cassette flanked with two homologous regions of a gene of interest, were prepared using overlap polymerase chain reaction (PCR). To generate the other transgenic parasites, a previously reported CRISPR/Cas9 system using PbCas9 parasites was used. Donor DNAs were constructed using overlap PCR, cloned into pBluescript KS (+), and amplified using PCR. Single guide RNA vectors were prepared by cloning target sequences using annealed oligos. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |